These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1974206)

  • 21. Carvedilol increases the systemic bioavailability of oral digoxin.
    De Mey C; Brendel E; Enterling D
    Br J Clin Pharmacol; 1990 Apr; 29(4):486-90. PubMed ID: 1970265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of clinical trial experience with epanolol.
    Blake P
    Drugs; 1989; 38 Suppl 2():81-5. PubMed ID: 2575988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
    Clark-Turner N
    Drugs; 1989; 38 Suppl 2():55-60. PubMed ID: 2575982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose finding in angina--results with epanolol.
    Omland TM; von Brandis C; Abrahamsen AM
    Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.
    Venneker EH; Remme WJ; van Hoogenhuyze DC; Krauss XH; Bartels GL; Kruijssen DA; Storm CJ; van Schelven D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):211-9. PubMed ID: 7918133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
    Blake P; Berry SC; Readman A; Ratcliffe M; Godley M
    Cardiology; 1991; 79(4):249-55. PubMed ID: 1685942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
    Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
    Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICI 141,292 (epanolol)--pharmacokinetics after single and repeated oral administration in the elderly with moderate renal impairment.
    Laher MS; Crome P; Rakhra GS; Ankier SI; Cockshott ID
    Eur J Clin Pharmacol; 1990; 39(1):71-4. PubMed ID: 1980462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
    Chambers J; Ong ML; Akhras F; Adam G; Jackson G
    Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
    Bilski AJ; Hadfield SE; Wale JL
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic doses.
    Peters J; Welker HA; Bullingham R
    Eur J Drug Metab Pharmacokinet; 1999; 24(2):133-40. PubMed ID: 10510740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of epanolol on quality of life.
    Jern S
    Drugs; 1989; 38 Suppl 2():71-4. PubMed ID: 2575987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.
    Tayrouz Y; Ding R; Burhenne J; Riedel KD; Weiss J; Hoppe-Tichy T; Haefeli WE; Mikus G
    Clin Pharmacol Ther; 2003 May; 73(5):397-405. PubMed ID: 12732840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects on physical performance of intrinsic sympathomimetic activity (ISA) during selective beta 1-blockade.
    Kullmer T; Kindermann W; Singer M
    Eur J Appl Physiol Occup Physiol; 1987; 56(3):292-8. PubMed ID: 2883003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular function during treatment with either metoprolol or epanolol.
    Evans T
    Drugs; 1989; 38 Suppl 2():70. PubMed ID: 2575986
    [No Abstract]   [Full Text] [Related]  

  • 38. The comparative cardiovascular effects of digoxin and food alone and in combination in normal males.
    Burgess CD; Crane J
    Eur J Clin Pharmacol; 1986; 29(6):685-9. PubMed ID: 3709610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Teriparatide has no effect on the calcium-mediated pharmacodynamics of digoxin.
    Benson CT; Voelker JR
    Clin Pharmacol Ther; 2003 Jan; 73(1):87-94. PubMed ID: 12545147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.